Patients with multiple myeloma, a blood cancer of plasma cells in the bone marrow, who also have diabetes have a reduced overall survival when compared to those without diabetes. In a subgroup analysis, this difference in survival due to diabetes was seen in White patients but not in Black patients, according to a new study.
Diabetes may accelerate blood cancer growth, yet survival outcomes differ by race
